You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
|
|---|---|
| Published in |
Nature Medicine, April 2024
|
| DOI | 10.1038/s41591-024-02894-y |
| Pubmed ID | |
| Authors |
Mark Yarchoan, Edward J. Gane, Thomas U. Marron, Renzo Perales-Linares, Jian Yan, Neil Cooch, Daniel H. Shu, Elana J. Fertig, Luciane T. Kagohara, Gabor Bartha, Josette Northcott, John Lyle, Sarah Rochestie, Joann Peters, Jason T. Connor, Elizabeth M. Jaffee, Ildiko Csiki, David B. Weiner, Alfredo Perales-Puchalt, Niranjan Y. Sardesai |
X Demographics
The data shown below were collected from the profiles of 144 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 26 | 18% |
| Japan | 25 | 17% |
| India | 3 | 2% |
| France | 3 | 2% |
| Canada | 2 | 1% |
| China | 2 | 1% |
| United Kingdom | 2 | 1% |
| Chile | 2 | 1% |
| Brazil | 2 | 1% |
| Other | 13 | 9% |
| Unknown | 64 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 107 | 74% |
| Scientists | 25 | 17% |
| Practitioners (doctors, other healthcare professionals) | 8 | 6% |
| Science communicators (journalists, bloggers, editors) | 4 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 22 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 32% |
| Student > Ph. D. Student | 6 | 27% |
| Student > Doctoral Student | 3 | 14% |
| Other | 2 | 9% |
| Student > Postgraduate | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 3 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 9 | 41% |
| Immunology and Microbiology | 4 | 18% |
| Engineering | 3 | 14% |
| Medicine and Dentistry | 2 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 2 | 9% |
Attention Score in Context
This research output has an Altmetric Attention Score of 756. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 May 2024.
All research outputs
#26,605
of 25,834,578 outputs
Outputs from Nature Medicine
#200
of 9,453 outputs
Outputs of similar age
#297
of 245,800 outputs
Outputs of similar age from Nature Medicine
#3
of 133 outputs
Altmetric has tracked 25,834,578 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,453 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 105.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,800 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 133 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.